The FDA announced on Oct. 9, 2026, that AvKARE is voluntarily recalling Fludrocortisone Acetate Tablets due to failed impurities and degradation specifications. The recall affects 8,866 cartons distributed nationwide.
How to tell if you have it
- Brand: AvKARE
- Product: Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK
- NDC: 50268-330-15
- Lot #: 48353
- Expiration Date: 10/31/2026
The hazard
The recall is due to failed impurities and degradation specifications. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show AvKARE has had 14 other recalls since March 28, 2024. Recent similar recalls include the AvKARE Amantadine Capsules Recall (Feb. 13, 2026), the AvKARE Rosuvastatin Tablets 10mg Recall (Dec. 31, 2025), and the AvKARE Hormone Tablets Recall (Sept. 2, 2025). Other recent recalls of similar products include the Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (Dec. 30, 2025), the Ajanta Pharma Fluphenazine Tablets Recall (Aug. 25, 2026), and the Ritedose Formoterol Fumarate Inhalation Solution Recall (Oct. 15, 2026).